Borregaard Tidigare resultatutveckling
Tidigare kriterier kontrolleras 2/6
Borregaard har ökat intäkterna med en genomsnittlig årlig takt på 2.3%, medan Chemicals -branschen såg intäkterna minskar på 2.8% årligen. Intäkterna har varit växande med en genomsnittlig takt på 7.1% per år. Borregaard s avkastning på eget kapital är 8.4% och den har en nettomarginal på 7.2%.
Viktig information
2.32%
Tillväxttakt i vinsten
2.26%
Tillväxttakt för EPS
| Chemicals Tillväxt i branschen | 32.60% |
| Intäkternas tillväxttakt | 7.05% |
| Avkastning på eget kapital | 8.38% |
| Nettomarginal | 7.17% |
| Nästa resultatuppdatering | 16 Jul 2026 |
Senaste uppdateringar av tidigare prestationer
Recent updates
BRG: Dividend Support And Volume Outlook Will Underpin Future Upside
Analysts have trimmed the Borregaard fair value estimate by NOK 1.0 to NOK 198.6. This reflects slightly adjusted assumptions on discount rate, revenue growth, profit margins and future P/E following mixed recent research, including a lower price target and a downgrade alongside a separate upgrade. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the recent upgrade signals confidence that current pricing already reflects much of the previous caution baked into Borregaard's shares.BRG: Dividend Support And Updated Volume Guidance Will Drive Future Upside
Narrative Update The analyst price target for Borregaard has been adjusted slightly from NOK 200 to around NOK 199.60, as analysts update their models with a lower discount rate, largely unchanged growth and margin assumptions, and a modestly higher future P/E, following a mix of recent upgrades and target cuts in Street research. Analyst Commentary Recent Street research around Borregaard has been mixed, with one upgrade and at least two cautious views.BRG: Dividend Support And Stable Earnings Profile Will Drive Future Upside
Analysts kept the fair value estimate for Borregaard steady at NOK 200, with only very small tweaks to inputs like the discount rate, revenue growth, profit margin, and future P/E, reflecting recent price target cuts and more cautious views in Street research. Analyst Commentary Bullish Takeaways Bullish analysts view the unchanged NOK 200 fair value estimate as a sign that the long term earnings and cash flow assumptions remain intact despite recent target cuts.BRG: Dividend Support And Niche Margin Resilience Will Drive Future Upside
Analysts have trimmed their Borregaard price targets, with one key house cutting its view by NOK 45. This reflects a more cautious stance that also feeds into slightly lower assumed discount rates and P/E multiples in updated models.BRG: Dividend And Margin Resilience Will Support Higher Future Fair Value
Analysts have trimmed their Borregaard price targets, with one cut of NOK 45 reflecting slightly higher discount rates and only marginal tweaks to long term revenue growth, profit margins and future P/E assumptions. Analyst Commentary Bullish Takeaways Bullish analysts appear comfortable that only marginal adjustments to long term revenue growth, profit margins and future P/E assumptions are needed, which suggests they still view the core earnings profile as intact.Borregaard (OB:BRG) Is Increasing Its Dividend To NOK4.75
Feb 08
BRG: Dividend Policy And Higher Margins Will Support Future Fair Value
Analysts have reduced their fair value estimate for Borregaard from NOK 211.40 to NOK 200.00, reflecting updated assumptions on the discount rate, revenue growth, profit margin and future P/E following recent research, including a downgrade from SEB Equities. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value of NOK 200.00 as still implying room for execution on revenue growth and margins, even after accounting for a higher discount rate and more cautious P/E assumptions.Is Now The Time To Look At Buying Borregaard ASA (OB:BRG)?
Feb 03BRG: Government Support And Bio Project Will Continue To Underpin Fair Value
Analysts have trimmed their fair value estimate for Borregaard slightly from NOK 212.50 to about NOK 211.40, reflecting modest adjustments to the discount rate, revenue growth, profit margin and forward P/E inputs. Valuation Changes Fair Value Estimate has been adjusted slightly from NOK 212.50 to about NOK 211.40.BRG: Government Support And Bio Project Will Support Fairly Valued Outlook
Analysts have kept their fair value estimate for Borregaard steady at NOK 212.50, with only slight technical adjustments to inputs such as discount rate, revenue growth, profit margin, and future P/E feeding into the updated price target rationale. Valuation Changes Fair Value: The fair value estimate is unchanged at NOK 212.50, with no modification to the central valuation point.BRG: Government Support And Bio Project Will Support Stable Future Outlook
Analysts have marginally raised their price target on Borregaard to NOK 212.50, citing slightly lower discount rate assumptions while keeping revenue growth, profit margin, and future P E expectations essentially unchanged. What's in the News Norwegian Research Council awards Borregaard NOK 15 million for its Biomer innovation project, supporting development of bio based alternatives to fossil based polycarboxylates used in agriculture, industry, and household products (Norwegian Research Council) Biomer project to leverage Borregaard’s Sarpsborg biorefinery and wood chemistry expertise to convert Norwegian bioresources into greener polymers with a significantly lower environmental footprint (Norwegian Research Council) Valuation Changes The fair value estimate remains unchanged at NOK 212.50 per share, indicating no revision to the overall intrinsic value assessment.BRG: Government Support And Stable Outlook Will Offset Temporary Production Disruption
Analysts have nudged their price target on Borregaard slightly higher to NOK 212.50, reflecting marginally lower discount rate assumptions and continued expectations for steady revenue growth, profit margins, and valuation multiples. What's in the News NOK 15 million in funding from the Norwegian Research Council will support Borregaard’s Biomer project, which aims to develop bio based alternatives to fossil based polycarboxylates used across agriculture, industry, and household products (Regulatory Authority: Compliance).BRG: Recent Government Support Will Strengthen Outlook Amid Temporary Production Disruption
Analysts have maintained Borregaard's price target at NOK 212.50. This reflects continued confidence in the company’s financial outlook, despite only marginal adjustments to key assumptions.BRG: Rising Bio-Based Support Will Drive Long-Term Upside Momentum
Analysts have revised Borregaard’s fair value target slightly downwards, from NOK 214.75 to NOK 212.50. They cite updated projections for profit margins and market conditions as influencing factors.Analysts Adjust Borregaard Price Target and Valuation Following Recent Updates and Ongoing Developments
Analysts have slightly lowered their price target for Borregaard from NOK 217.50 to NOK 214.75. This change is due to minor adjustments in discount rate and valuation metrics after reviewing updated forecasts.Borregaard (OB:BRG) Is Experiencing Growth In Returns On Capital
Sep 17We Think Borregaard (OB:BRG) Can Stay On Top Of Its Debt
Sep 02Analysts Are Updating Their Borregaard ASA (OB:BRG) Estimates After Its Second-Quarter Results
Jul 19If EPS Growth Is Important To You, Borregaard (OB:BRG) Presents An Opportunity
Jun 10Borregaard ASA (OB:BRG) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 03Here's Why Borregaard ASA's (OB:BRG) CEO Compensation Is The Least Of Shareholders Concerns
Apr 04There's Reason For Concern Over Borregaard ASA's (OB:BRG) Price
Mar 19
BioSolutions Expansion And Environmental Initiatives Will Benefit Future Operations
Focus on high-value products and specialization in BioSolutions and BioMaterials aims to improve product mix and enhance net margins.Borregaard ASA (OB:BRG) Just Released Its Yearly Earnings: Here's What Analysts Think
Feb 01Returns Are Gaining Momentum At Borregaard (OB:BRG)
Jan 24Borregaard ASA's (OB:BRG) Business Is Yet to Catch Up With Its Share Price
Nov 21Here's Why Borregaard (OB:BRG) Can Manage Its Debt Responsibly
Sep 21Borregaard (OB:BRG) Shareholders Will Want The ROCE Trajectory To Continue
Aug 31Borregaard ASA's (OB:BRG) Share Price Not Quite Adding Up
Jul 23Here's Why Borregaard (OB:BRG) Can Manage Its Debt Responsibly
Jun 22Calculating The Fair Value Of Borregaard ASA (OB:BRG)
Jun 07This Is Why We Think Borregaard ASA's (OB:BRG) CEO Might Get A Pay Rise Approved By Shareholders
Apr 05This Is Why We Think Borregaard ASA's (OB:BRG) CEO Might Get A Pay Rise Approved By Shareholders
Apr 05These 4 Measures Indicate That Borregaard (OB:BRG) Is Using Debt Reasonably Well
Feb 12There's Reason For Concern Over Borregaard ASA's (OB:BRG) Price
Jan 27Investors Will Want Borregaard's (OB:BRG) Growth In ROCE To Persist
Jan 06Calculating The Intrinsic Value Of Borregaard ASA (OB:BRG)
Nov 03Here's Why Borregaard (OB:BRG) Can Manage Its Debt Responsibly
Oct 19Is Now The Time To Put Borregaard (OB:BRG) On Your Watchlist?
Sep 26Borregaard (OB:BRG) Is Investing Its Capital With Increasing Efficiency
Sep 07Fördelning av intäkter och kostnader
Fördelning av intäkter och kostnader
Hur Borregaard tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Mar 26 | 7,682 | 551 | 1,553 | 0 |
| 31 Dec 25 | 7,713 | 620 | 1,553 | 0 |
| 30 Sep 25 | 7,624 | 830 | 1,441 | 0 |
| 30 Jun 25 | 7,774 | 885 | 1,441 | 0 |
| 31 Mar 25 | 7,678 | 874 | 1,441 | 0 |
| 31 Dec 24 | 7,617 | 823 | 1,441 | 0 |
| 30 Sep 24 | 7,478 | 813 | 1,359 | 0 |
| 30 Jun 24 | 7,243 | 800 | 1,359 | 0 |
| 31 Mar 24 | 7,257 | 839 | 1,359 | 0 |
| 31 Dec 23 | 7,132 | 870 | 1,359 | 0 |
| 30 Sep 23 | 7,297 | 935 | 1,204 | 0 |
| 30 Jun 23 | 7,335 | 937 | 1,204 | 0 |
| 31 Mar 23 | 7,116 | 906 | 1,204 | 0 |
| 31 Dec 22 | 6,881 | 892 | 1,204 | 0 |
| 30 Sep 22 | 6,557 | 810 | 1,158 | 0 |
| 30 Jun 22 | 6,234 | 782 | 1,158 | 0 |
| 31 Mar 22 | 6,001 | 763 | 1,158 | 0 |
| 31 Dec 21 | 5,805 | 692 | 1,158 | 0 |
| 30 Sep 21 | 5,697 | 711 | 1,142 | 0 |
| 30 Jun 21 | 5,528 | 612 | 1,142 | 0 |
| 31 Mar 21 | 5,375 | 480 | 1,142 | 0 |
| 31 Dec 20 | 5,328 | 436 | 1,142 | 0 |
| 30 Sep 20 | 5,224 | 353 | 1,098 | 0 |
| 30 Jun 20 | 5,203 | 372 | 1,098 | 0 |
| 31 Mar 20 | 5,185 | 393 | 1,098 | 0 |
| 31 Dec 19 | 5,063 | 417 | 1,098 | 0 |
| 30 Sep 19 | 5,048 | 459 | 1,083 | 0 |
| 30 Jun 19 | 4,959 | 455 | 1,083 | 0 |
| 31 Mar 19 | 4,818 | 465 | 1,083 | 0 |
| 31 Dec 18 | 4,785 | 476 | 1,083 | 0 |
| 30 Sep 18 | 4,703 | 486 | 1,025 | 0 |
| 30 Jun 18 | 4,642 | 506 | 1,025 | 0 |
| 31 Mar 18 | 4,699 | 555 | 1,025 | 0 |
| 31 Dec 17 | 4,618 | 566 | 1,025 | 0 |
| 30 Sep 17 | 4,591 | 599 | 955 | 0 |
| 30 Jun 17 | 4,604 | 609 | 955 | 0 |
| 31 Mar 17 | 4,515 | 582 | 955 | 0 |
| 31 Dec 16 | 4,492 | 555 | 955 | 0 |
| 30 Sep 16 | 4,416 | 540 | 887 | 0 |
| 30 Jun 16 | 4,383 | 495 | 887 | 0 |
| 31 Mar 16 | 4,270 | 433 | 887 | 0 |
| 31 Dec 15 | 4,164 | 386 | 887 | 0 |
| 30 Sep 15 | 4,081 | 346 | 813 | 0 |
| 30 Jun 15 | 4,015 | 344 | 813 | 0 |
Kvalitetsintäkter: BRG har inkomster av hög kvalitet.
Växande vinstmarginal: BRG s nuvarande netto vinstmarginaler (7.2%) är lägre än förra året (11.4%).
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: BRG s intäkter har ökat med 2.3% per år under de senaste 5 åren.
Accelererande tillväxt: BRG s har haft negativ intäktstillväxt under det senaste året, så det kan inte jämföras med dess 5-åriga genomsnitt.
Resultat vs industri: BRG hade negativ intäktstillväxt ( -37% ) under det senaste året, vilket gör det svårt att jämföra med branschens genomsnitt Chemicals ( 1.3% ).
Avkastning på eget kapital
Hög ROE: BRG s avkastning på eget kapital ( 8.4% ) anses vara låg.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/03 12:48 |
| Aktiekurs vid dagens slut | 2026/04/30 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Borregaard ASA bevakas av 5 analytiker. 5 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Andres Castanos-Mollor | Berenberg |
| Elliott Geoffrey Jones | Danske Bank |